Your email has been successfully added to our mailing list.

×
0 0 -0.014336917562724 -0.021505376344086 -0.021505376344086 -0.0286738351254481 -0.025089605734767 -0.00716845878136201
Stock impact report

Selecta Biosciences Says FDA Puts Clinical Hold on SEL-302 Trial, Shares Lower [MarketWatch]

Selecta Biosciences, Inc. (SELB) 
Last selecta biosciences, inc. earnings: 3/12 08:00 am Check Earnings Report
Company Research Source: MarketWatch
Food and Drug Administration placed a clinical hold on its Phase 1/2 clinical trial of SEL-302 to treat patients with methylmalonic acidemia. The company said SEL-302 consists of MMA-101 plus ImmTOR. Selecta Biosciences also said on Nov. 23 it received a letter from the FDA "issuing a clinical hold in order to obtain additional information on the chemistry, manufacturing and controls related to the MMA-101 product candidate." "Patient safety is our primary concern, and we are committed to addressing the FDA's questions regarding CMC as expeditiously as possible," said Carsten Brunn, president and chief executive. At 5:35 p.m. ET, shares of Selecta Biosciences were trading 13.2% lower at $2.76 a share. Volume at the time topped 150,000 shares. Write to Stephen Nakrosis at stephen.nakrosis@wsj.com Show less Read more
Impact Snapshot
Event Time:
SELB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for SELB alerts
Opt-in for
SELB alerts

from News Quantified
Opt-in for
SELB alerts

from News Quantified